Nektar Therapeutics (NKTR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Nektar Therapeutics, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$38.55
+1.53% today
Market cap
$1.3B
Overall quality
—
Kronos AI 30-day
+60.1%
8 of 8 simulated paths end higher
Nektar Therapeutics (NKTR) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.3B. It trades at $38.55, up 1.53% today. 13 analysts' average target of $132.45 implies +243.6% from today's price. Kronos AI's 30-day forecast is +60.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $132.45 |
| Low – high | $50.00 – $192.00 |
| Analysts | 13 |
| Upside to average | +243.6% |
Kronos AI 30-day forecast
| Expected close | $60.80 (+60.1%) |
| Likely range | +56.6% … +70.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.